Finnrick - Ensuring a Safer and More Transparent Supply Chain
Nexaph

Nexaph
Retatrutide

Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Nexaph between 11 Jun 2025 and 3 Jul 2025. Test scores average over 4, no score below 3, and at least 2 tests warrant a tentative Finnrick Rating of D (Poor).

Finnrick Rating™
D
POOR
Tentative Rating
Nexaph
Retatrutide
Tested 2 Samples
Last test 3 Jul 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Nexaph

Samples are tested in commercial labs

Tests Count

2

Scores

AVG5.4MIN3.8MAX7.0

Last

3 Jul 2025

First

11 Jun 2025
Quantity
Test DateCertificate
Test Score
Label
Batch
TestedDifferencePurityBatch IDContainerTested AtSent By
3 Jul 2025View7.06mg(no batch claim)6.220mg+3.7%99.00%RET0604302025-04No Label / Copper Crimp / Black CapLab EPublic
11 Jun 2025View3.86mg
6.5mg
5.820mg-10.7%97.34%RET0604302025-04No Label / Gold Crimp / Black CapLab EFinnrick